Jared Barsky
Examiner (ID: 13656, Phone: (571)272-2795 , Office: P/1628 )
Most Active Art Unit | 1628 |
Art Unit(s) | 1628 |
Total Applications | 964 |
Issued Applications | 443 |
Pending Applications | 93 |
Abandoned Applications | 428 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11418995
[patent_doc_number] => 20170027139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'ANIMAL MODELS OF AGE-RELATED DISORDERS AND AGE-SENSITIVE TRAITS ASSOCIATED WITH SENESCENCE-INDUCING STIMULI AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/067543
[patent_app_country] => US
[patent_app_date] => 2016-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17703
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15067543
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/067543 | Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells | Mar 10, 2016 | Issued |
Array
(
[id] => 11022892
[patent_doc_number] => 20160219847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'COMMON LIGHT CHAIN MOUSE'
[patent_app_type] => utility
[patent_app_number] => 15/056713
[patent_app_country] => US
[patent_app_date] => 2016-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 53724
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15056713
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/056713 | COMMON LIGHT CHAIN MOUSE | Feb 28, 2016 | Abandoned |
Array
(
[id] => 15309499
[patent_doc_number] => 10519440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-31
[patent_title] => Composition and method of using miR-302 precursors as drugs for treating Alzheimer's diseases
[patent_app_type] => utility
[patent_app_number] => 15/048964
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 45
[patent_no_of_words] => 15619
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15048964
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/048964 | Composition and method of using miR-302 precursors as drugs for treating Alzheimer's diseases | Feb 18, 2016 | Issued |
Array
(
[id] => 11625137
[patent_doc_number] => 20170135326
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2017-05-18
[patent_title] => 'NON-HUMAN ANIMALS WITH MODIFIED IMMUNOGLOBULIN HEAVY CHAIN SEQUENCES'
[patent_app_type] => utility
[patent_app_number] => 14/961642
[patent_app_country] => US
[patent_app_date] => 2015-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 107
[patent_figures_cnt] => 107
[patent_no_of_words] => 66245
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14961642
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/961642 | Non-human animals with modified immunoglobulin heavy chain sequences | Dec 6, 2015 | Issued |
Array
(
[id] => 11625137
[patent_doc_number] => 20170135326
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2017-05-18
[patent_title] => 'NON-HUMAN ANIMALS WITH MODIFIED IMMUNOGLOBULIN HEAVY CHAIN SEQUENCES'
[patent_app_type] => utility
[patent_app_number] => 14/961642
[patent_app_country] => US
[patent_app_date] => 2015-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 107
[patent_figures_cnt] => 107
[patent_no_of_words] => 66245
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14961642
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/961642 | Non-human animals with modified immunoglobulin heavy chain sequences | Dec 6, 2015 | Issued |
Array
(
[id] => 10706839
[patent_doc_number] => 20160052986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'HUMANIZED IL-7 RODENTS'
[patent_app_type] => utility
[patent_app_number] => 14/937270
[patent_app_country] => US
[patent_app_date] => 2015-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8713
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14937270
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/937270 | HUMANIZED IL-7 RODENTS | Nov 9, 2015 | Abandoned |
Array
(
[id] => 12058665
[patent_doc_number] => 20170335009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'TETRAVALENT TLR9 BISPECIFIC ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 15/522955
[patent_app_country] => US
[patent_app_date] => 2015-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10421
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15522955
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/522955 | TETRAVALENT TLR9 BISPECIFIC ANTIBODY | Oct 29, 2015 | Abandoned |
Array
(
[id] => 11236164
[patent_doc_number] => 09462794
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-11
[patent_title] => 'Non-human animals having a humanized signal-regulatory protein gene'
[patent_app_type] => utility
[patent_app_number] => 14/882531
[patent_app_country] => US
[patent_app_date] => 2015-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17576
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14882531
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/882531 | Non-human animals having a humanized signal-regulatory protein gene | Oct 13, 2015 | Issued |
Array
(
[id] => 17936397
[patent_doc_number] => 11470826
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Method of conveniently producing genetically modified non-human mammal with high efficiency
[patent_app_type] => utility
[patent_app_number] => 15/527085
[patent_app_country] => US
[patent_app_date] => 2015-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6249
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15527085
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/527085 | Method of conveniently producing genetically modified non-human mammal with high efficiency | Oct 5, 2015 | Issued |
Array
(
[id] => 18545491
[patent_doc_number] => 11718832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Method to reduce oncogenic potential of induced pluripotent stem cells from aged donors
[patent_app_type] => utility
[patent_app_number] => 15/517014
[patent_app_country] => US
[patent_app_date] => 2015-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 23935
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517014
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/517014 | Method to reduce oncogenic potential of induced pluripotent stem cells from aged donors | Oct 5, 2015 | Issued |
Array
(
[id] => 10679561
[patent_doc_number] => 20160025706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY'
[patent_app_type] => utility
[patent_app_number] => 14/875725
[patent_app_country] => US
[patent_app_date] => 2015-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4546
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14875725
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/875725 | METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY | Oct 5, 2015 | Abandoned |
Array
(
[id] => 11656076
[patent_doc_number] => 09669058
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-06
[patent_title] => 'Engineering and delivery of therapeutic compositions of freshly isolated cells'
[patent_app_type] => utility
[patent_app_number] => 14/834932
[patent_app_country] => US
[patent_app_date] => 2015-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 15121
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14834932
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/834932 | Engineering and delivery of therapeutic compositions of freshly isolated cells | Aug 24, 2015 | Issued |
Array
(
[id] => 12057181
[patent_doc_number] => 20170333524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'MOLECULAR CONSTRUCTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/327984
[patent_app_country] => US
[patent_app_date] => 2015-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13827
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15327984
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/327984 | Molecular constructs and uses thereof | Jul 21, 2015 | Issued |
Array
(
[id] => 11668468
[patent_doc_number] => 20170157188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/325562
[patent_app_country] => US
[patent_app_date] => 2015-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18701
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325562
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/325562 | Oncolytic virus for expression of immune checkpoint modulators | Jul 15, 2015 | Issued |
Array
(
[id] => 10466356
[patent_doc_number] => 20150351371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'Hybrid Light Chain Mice'
[patent_app_type] => utility
[patent_app_number] => 14/800257
[patent_app_country] => US
[patent_app_date] => 2015-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 26462
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14800257
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/800257 | Hybrid light chain mice | Jul 14, 2015 | Issued |
Array
(
[id] => 10421135
[patent_doc_number] => 20150306147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'ISOLATED LIVER STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/795195
[patent_app_country] => US
[patent_app_date] => 2015-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 28540
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14795195
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/795195 | Isolated liver stem cells | Jul 8, 2015 | Issued |
Array
(
[id] => 10411746
[patent_doc_number] => 20150296755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'TRANSGENIC ANIMALS CAPABLE OF BEING INDUCED TO DELETE SENESCENT CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/792208
[patent_app_country] => US
[patent_app_date] => 2015-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 8272
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14792208
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/792208 | Transgenic animals capable of being induced to delete senescent cells | Jul 5, 2015 | Issued |
Array
(
[id] => 10387990
[patent_doc_number] => 20150272997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'Mesenchymal Stem Cells and Uses Therefor'
[patent_app_type] => utility
[patent_app_number] => 14/739924
[patent_app_country] => US
[patent_app_date] => 2015-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9886
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14739924
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/739924 | Mesenchymal Stem Cells and Uses Therefor | Jun 14, 2015 | Abandoned |
Array
(
[id] => 11568854
[patent_doc_number] => 20170107498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'NOVEL AND EFFICIENT METHOD FOR REPROGRAMMING IMMORTALIZED LYMPHOBLASTOID CELL LINES TO INDUCED PLURIPOTENT STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/316098
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13288
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316098
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/316098 | NOVEL AND EFFICIENT METHOD FOR REPROGRAMMING IMMORTALIZED LYMPHOBLASTOID CELL LINES TO INDUCED PLURIPOTENT STEM CELLS | Jun 4, 2015 | Abandoned |
Array
(
[id] => 10361971
[patent_doc_number] => 20150246976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'Hybrid Light Chain Mice'
[patent_app_type] => utility
[patent_app_number] => 14/715145
[patent_app_country] => US
[patent_app_date] => 2015-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 26436
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14715145
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/715145 | Hybrid light chain mice | May 17, 2015 | Issued |